Phathom Pharmaceuticals price target raised by $6 at Cantor Fitzgerald, here's why
Phathom Pharmaceuticals(PHAT) Thefly·2025-06-07 01:05Proprietary deal commentary available to members only. Sign up or login for access.Proprietary deal commentary available to members only. Sign up or login for access.Proprietary deal commentary available to members only. Sign up or login for access.Wed KNTKX KNTK Kinetik Holdings Block Trade Managers: Goldman SachsPriced at: $44.404.3M SharesSpecial CommentsExclusive Analysis LockedProprietary deal commentary available to members only. Sign up or login for access. Create FREE AccountProprietary deal comm ...